These results are in agreement with previous findings in both NSCLC tissues and cell lines [36], and with the hypothesis that activator protein-1, which is activated by EGFR signaling [37], can in turn activate the miR-21 transcription through the binding to the promoter [38]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.